We are live on ! Find out more
BIND

BIND THERAPEUTICS INC
BIND

Delisted

BIND was delisted on the 29th of July, 2016.

Back to rankings

42 hedge funds and large institutions have $51.2M invested in BIND THERAPEUTICS INC in 2013 Q4 according to their latest regulatory filings, with 39 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,850% more first-time investments, than exits

New positions opened: 39 | Existing positions closed: 2

740% more funds holding

Funds holding: 5 → 42 (+37)

249% more capital invested

Capital invested by funds: $14.7M → $51.2M (+$36.6M)

100% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 1

Holders
42
Holders Change
+37
Holders Change %
+740%
% of All Funds
1.22%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
39
Increased
2
Reduced
1
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
EMFAT
Emerald Mutual Fund Advisers Trust
Pennsylvania
+$5.76M
2
Franklin Resources
Franklin Resources
California
+$4.31M
3
Principal Financial Group
Principal Financial Group
Iowa
+$3.99M
4
PI
Putnam Investments
Massachusetts
+$3.82M
5
DM
Deerfield Management
New York
+$3.26M

Top Sellers

Rank Fund Capital Flow
1
BCPEM
Bain Capital Public Equity Management
Massachusetts
-$6.35M
2
WSA
Wall Street Associates
California
-$1.76M
3
Alyeska Investment Group
Alyeska Investment Group
Illinois
-$514K
Name Holding Trade Value Shares
Change 		Change in
Stake
PCM
26
Prelude Capital Management
New York
$196K +$165K +13,000 New
BIM
27
BlackRock Investment Management
Delaware
$190K +$160K +12,559 New
MWNA
28
Marshall Wace North America
New York
$154K +$130K +10,200 New
California State Teachers Retirement System (CalSTRS)
29
California State Teachers Retirement System (CalSTRS)
California
$145K +$122K +9,600 New
Morgan Stanley
30
Morgan Stanley
New York
$138K +$117K +9,182 New
Citigroup
31
Citigroup
New York
$85K +$71.4K +5,613 New
TA
32
Teachers Advisors
New York
$79K +$66.5K +5,230 New
NFA
33
Nationwide Fund Advisors
Ohio
$60K +$50.3K +3,951 New
AIG
34
American International Group
New York
$53K +$44.7K +3,511 New
Wells Fargo
35
Wells Fargo
California
$41K +$35.3K +2,771 New
SO
36
STRS Ohio
Ohio
$32K +$26.7K +2,100 New
U
37
UBS
Switzerland
$24K +$20.4K +1,600 New
TDC
38
Thompson Davis & Co
Virginia
$23K +$19.1K +1,500 New
PNC Financial Services Group
39
PNC Financial Services Group
Pennsylvania
$15K +$12.7K +1,000 New
BJ
40
BlackRock Japan
Japan
$6K +$4.8K +377 New
Bank of America
41
Bank of America
North Carolina
$2K +$1.27K +100 New
Barclays
42
Barclays
United Kingdom
$1K +$1.09K +86 New
BCPEM
43
Bain Capital Public Equity Management
Massachusetts
– -$6.35M -450,000 Closed
WSA
44
Wall Street Associates
California
– -$1.76M -125,000 Closed
1
2

BIND Hedge Fund Activity: Q4 2013 in Review

42 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in BIND THERAPEUTICS INC (BIND) for Q4 2013, worth a combined $51.2M — up 249% from $14.7M a quarter earlier.

Buyers outnumbered sellers: 39 funds opened new BIND positions and 2 closed out — a net gain of 37 holders — while 2 added to existing stakes and 1 trimmed.

The largest buyer was Emerald Mutual Fund Advisers Trust, adding an estimated $5.76M. The largest seller was Bain Capital Public Equity Management, exiting entirely with an estimated $6.35M sold.

  • 42 institutional investors held BIND THERAPEUTICS INC (BIND) as of Q4 2013, up from 5 in Q3 2013.
  • Funds reported $51.2M of BIND THERAPEUTICS INC stock for Q4 2013, up 249% quarter-over-quarter.
  • 39 funds opened new BIND THERAPEUTICS INC positions in Q4 2013 and 2 closed out, a net change of +37 holders.
  • The largest BIND THERAPEUTICS INC buyer in Q4 2013 was Emerald Mutual Fund Advisers Trust, an estimated $5.76M added.
  • The largest BIND THERAPEUTICS INC seller in Q4 2013 was Bain Capital Public Equity Management, an estimated $6.35M sold.

Based on aggregated 13F filings for Q4 2013.